![PDF) 1478PEfficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) PDF) 1478PEfficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)](https://i1.rgstatic.net/publication/328453907_1478PEfficacy_of_second-line_nivolumab_after_early_time_to_progression_on_first-line_cytotoxic_chemotherapy_in_patients_with_advanced_non-small_cell_lung_cancer_NSCLC/links/5bcf1fde4585152b144f7cba/largepreview.png)
PDF) 1478PEfficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)
![PDF) Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy) PDF) Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)](https://i1.rgstatic.net/publication/337647196_Perspectives_in_immunotherapy_meeting_report_from_the_Immunotherapy_Bridge_2018_28-29_November_2018_Naples_Italy/links/5de1caf5299bf10bc3314d8c/largepreview.png)
PDF) Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
1309P A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer
![PDF) 1479PFirst analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG) PDF) 1479PFirst analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG)](https://i1.rgstatic.net/publication/328454371_1479PFirst_analysis_of_patients_p_with_stage_IV_non-small_cell_lung_cancer_NSCLC_of_the_thoracic_tumor_registry_RTT_of_the_Spanish_Lung_Cancer_Group_SLCG/links/5bcf205aa6fdcc204a01f828/largepreview.png)
PDF) 1479PFirst analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG)
![PDF) 345OThe survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors PDF) 345OThe survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors](https://i1.rgstatic.net/publication/329176293_345OThe_survivorship_experience_of_patients_with_metastatic_melanoma_on_long-term_immune_checkpoint_inhibitors/links/5c0efca54585157ac1b90efc/largepreview.png)